Prediction of therapeutic response in acute myelocytic leukemia.
D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism; D001562:Benzimidazoles; D001692:Biological Transport; D003561:Cytarabine / Q000008:administration & dosage* / Q000378:metabolism; D004273:DNA, Neoplasm; D004317:Doxorubicin / Q000008:administration & dosage* / Q000378:metabolism; D004359:Drug Therapy, Combination; D005453:Fluorescence; D005456:Fluorescent Dyes; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism; D010766:Phosphorylation
D001562:Benzimidazoles; D004273:DNA, Neoplasm; D005456:Fluorescent Dyes; D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate; D004317:Doxorubicin; C017807:bisbenzimide ethoxide trihydrochloride